Krensavage Asset Management, LLC
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 1609251
NEW YORK, NY
Position in ENTA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,788,292
+$5,588,970 QoQ
Shares Held
2,866,138
0.0% QoQ
Ownership
9.84%
of shares outstanding
% of Portfolio
15.88%
of 13F equity value
Holder Rank
#3
of 121 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Krensavage Asset Management, LLC holds $164,705,918 across 9 Biotechnology names. ENTA ranks #1 (25.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ENTA |
Enanta Pharmaceuticals Inc
This page
|
2,866,138 | $41,788,292 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
167,816 | $40,438,621 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
524,786 | $30,028,254 | |
| 4 | EXEL |
Exelixis, Inc.
|
370,693 | $20,169,406 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
390,879 | $13,051,449 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
1,180,388 | $7,223,974 | |
| 7 | BNTX |
BioNTech SE
|
59,523 | $5,538,615 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,000 | $3,741,240 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,788,292 | 2,866,138 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $36,199,322 | 2,866,138 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $43,625,970 | 2,766,390 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $25,309,894 | 2,114,444 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $15,985,196 | 2,114,444 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $11,683,554 | 2,116,586 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $15,520,046 | 1,498,074 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $16,229,853 | 1,251,338 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $19,635,271 | 1,124,586 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,989,973 | 742,824 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,211,100 | 735,103 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $14,714,918 | 687,613 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,397,492 | 603,301 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $27,670,933 | 594,818 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $30,570,103 | 589,360 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $29,532,783 | 624,768 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $39,065,577 | 548,828 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $42,183,547 | 564,102 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $53,218,301 | 936,777 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $41,353,996 | 939,650 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $42,555,663 | 862,848 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $36,155,943 | 858,811 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $37,783,561 | 825,329 | Shares | Sole | 2020-12-08 | |
| 2020-06-30 | $38,315,401 | 763,103 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $36,017,354 | 700,318 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||